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Abstract 
Recent studies suggest that Staphylococcus aureus enterotoxin sensitization is a risk factor for 
asthma. However, there is still limited epidemiologic evidence to support the associations in 
adult asthma.  
The present analyses were performed using the baseline dataset of Korean adult population 
surveys, consisting of 1,080 adults (mean age = 60.2 years) recruited from two rural 
community areas. Questionnaires, methacholine challenge tests, allergen skin tests and stool 
exams (Clonorchis sinensis eggs) were performed for defining clinical phenotypes. Sera were 
analyzed for total IgE and enterotoxin specific IgE using ImmunoCAP. 
Staphylococcal enterotoxin sensitization (≥ 0.35 kU/L) had a prevalence of 27.0%. Risk 
factors were identified as male sex, current smoking, advanced age, and atopy. Current asthma 
had a prevalence of 5.5%, and was mostly late in onset (93.8%). Using multivariate logistic 
regression, late-onset asthma was independently associated with high enterotoxin specific IgE 
levels. In multivariate linear regressions, Staphylococcal enterotoxin specific IgE level was 
identified as the major determinant for total IgE level. 
These findings suggest the clinical significance of Staphylococcal enterotoxin sensitization in 
late-onset adult asthma.  
Word count: 174 
Key words: asthma; bacteria; epidemiology of asthma 
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Introduction 
Asthma is now considered as a heterogeneous disorder [1] . Particularly, adult-onset asthma 
may have more complex pathogenic mechanisms other than the conventional Th2-mediated 
model which is largely mediated by atopy [1, 2].  
Staphylococcus aureus is a human commensal microorganism that is responsible for various 
invasive infectious diseases [3]. However, the superantigenic properties of Staphylococcal 
enterotoxins (SE) [4] have been also associated with allergic diseases in the skin [5] and upper 
airways [6].  
Recently, immune responses driven by SE have been linked to adult asthma [6, 7]. This 
relationship was supported by case-control studies [7-11] and meta-analyses [12, 13] of 
associations between SE-specific IgE (SE-sIgE) levels and asthma. More recently, a GA
2
LEN 
survey was conducted to investigate the association for the first time in the general adult 
population [14]. However, further evidence is needed to prove the roles of SE sensitization in 
adult asthma. 
The present analysis aimed to investigate the epidemiologic features and the clinical 
significance of SE sensitization, including risk factors and relationships with asthma and 
allergic parameters, using epidemiologic surveys of Korean adult community populations.  
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Methods 
Study population 
Cross-sectional surveys were previously conducted on adults living in two regions in Korea in 
2007 [15]. The two study regions are endemic for clonorchiasis and in Gyeongnam Province: 
Shinan-meon in Sancheong and Buk-meon in Changwon. Both regions are mainly agricultural 
areas, but Sancheong is more rural than Changwon. The surveys were conducted by 
collaboration between the Clinical Research Center for Chronic Obstructive Airway Disease 
of Seoul National University Hospital and Seoul National University Bundang Hospital and 
the National Cancer Center of Korea. The study protocol was reviewed and approved by the 
institutional review board.  
Study participants were recruited in collaboration with Public Health Centers in the study 
regions. Briefly, a leaflet and information materials detailing the study purpose and protocols 
were distributed to residents by the head of each village. The residents were contacted directly 
or by telephone calls for enrollment. In total, 1,116 subjects who were at least 30 years of age 
recruited voluntarily from a target population of 17,494 residents (616 subjects from 5,526 
Sancheong residents and 500 subjects from 11,968 Changwon residents). All participants 
provided written informed consent. Our final analysis included 1,080 subjects (96.8%) who 
had serum available for IgE measurements.  
Questionnaires 
Interviews were performed by trained researchers who were certified to conduct 
epidemiological surveys. The structured questionnaires included demographic parameters, 
medical history and allergic disease history. Medical histories included items on 40 common 
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chronic illnesses. The presence of allergic diseases was assessed using questionnaires on 
asthma and rhinitis, as described previously [16].  
Phenotype definitions 
Current asthma was defined positive if the subjects had current wheeze (“Have you had a 
wheezing or whistling in the chest during the last 12 months?”) and methacholine airway 
hyperresponsiveness (AHR), or had used asthma medication within the last 12 months 
(defined as recent asthma treatment). Past asthma was defined by prior asthma diagnosis in 
history but no recent symptoms, negative AHR, and no asthma treatment within the last 12 
months. Asthma was further classified by a participant-recalled asthma onset of 40 years as 
‘early-onset’ or ‘late-onset’. Rhinitis was defined by the question “Have you had a problem 
with sneezing or a runny or blocked nose without a cold in the last 12 months?”  
Methacholine challenge tests  
Methacholine challenge tests were performed using a modification of Chai’s method to 
measure AHR. Lung functions were measured by a portable spirometer (Micro Spirometer, 
Micro Medical, Kent, UK). Subjects with respiratory infections within the previous two 
weeks were excluded to avoid false-positive AHR. Subjects with a baseline forced expiratory 
volume 1 s (FEV1) of lower than either 1,200 mL or 50% of the predicted value were also 
excluded because of the presence of chronic obstructive pulmonary disease. A Rosenthal-
French dosimeter (Laboratory for Applied Immunology, Baltimore, MD, USA) was used to 
deliver aerosols generated by a nebulizer (DeVilbliss, Carlsbad, CA, USA). Subjects were 
instructed to inhale five inspiratory capacity breaths of increasing methacholine concentration 
(1.25, 2.5, 6.25, 12.5, and 25 mg/mL) until the FEV1 decreased to < 80% of the baseline 
value or until the highest concentration was reached. Triplicate FEV1 measurements were 
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recorded at 90 or 180 s after each inhalation, and the highest value was selected for analysis. 
Methacholine AHR was scored as positive if the concentration of methacholine provoking a 
20% decrease in FEV1 was < 16 mg/mL.  
Allergen skin prick test 
Skin testing was performed using a panel of 10 common inhalant allergens, including 
Dermatophagoides pteronyssinus, Dermatophagoides farinae, dog epithelia, Blatella 
germanica, fungus mixture, tree pollen mixture 1 (alder, hazel, popular, elm, and willow), tree 
pollen mixture 2 (birch, beech, oak, and plane tree), grass pollen mixture (velvet grass, 
orchard grass, rye grass, timothy grass, Kentucky blue grass, and meadow grass), mugwort, 
and ragweed. Positive (1 mg/mL histamine) and negative (0.9% sodium chloride) controls 
were also tested. The skin response was defined positive if the allergen wheal was larger than 
or equal in size to the histamine wheal and the diameter of the allergen wheal was at least 3 
mm. Atopy was determined when the subjects had a positive skin response to any of the tested 
allergens.  
Serum total IgE and specific IgE measurements for staphylococcal enterotoxin  
Serum samples were assayed for total IgE and SE-sIgE levels using the ImmunoCAP 250 
(Thermo Fischer, Uppsala, Sweden) according to the manufacturer’s instructions. SE-sIgE 
was measured using a Staphylococcal enterotoxin mix (SEA, SEC and TSST-1; Thermo 
Fischer, Uppsala, Sweden), as previously described [7].  
Other assessments 
Height and weight were measured to the nearest 0.1 cm or 0.1 kg in barefoot individuals 
wearing light clothing. Body mass index (BMI) was calculated by dividing weight by height 
squared. Stool samples were analyzed for Clonorchis sinensis infection using the Kato-Katz 
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method, and the intensity of infection was described as eggs per gram of feces (EPG) as 
previously described [15].  
Statistical analyses 
Descriptive data were calculated as the mean ± standard deviation, median [interquartile range 
(IQR)], or percentages. Data were compared by a t-test, Mann-Whitney test, one-way 
ANOVA or chi-squared test. Correlations between continuous variables were evaluated using 
Spearman bivariate tests. Logistic regression tests were performed to identify risk factors for 
SE sensitization or asthma. Factors for adjustments were selected when P < 0.10 in univariate 
logistic regression tests or if they were traditional risk factors. Multiple correspondence 
analyses were used to determine the relationships between identified risk factors and SE 
sensitization. For the asthma logistic regression test, the control group was defined as subjects 
that did not have current or past asthma. Linear regression models were used to identify 
determinants for total IgE levels. All the statistical analyses were performed using the Stata 
12.0 software package (Stata Corporation, College Station, TX, USA).  
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Results 
Baseline characteristics 
In total, 1,080 subjects were included in the analysis (Table 1). The population had a mean 
age of 60.2 ± 11.5 yrs, was predominantly female (62.8%) and had an average BMI for 
Korean adults (mean 23.6 ± 3.2 kg/m
2
), with no differences between the Sancheong and 
Changwon areas. The prevalence of atopy and current asthma was 12.0% and 5.5%, 
respectively. Most of current asthma (93.8%) was late-onset. The prevalence of SE 
sensitization was 27.0% when defined by the ≥ 0.35 kU/L cutoff (or 55.7% by the ≥ 0.10 
kU/L cutoff) without significant difference between areas. The prevalence of SE sensitization, 
atopy and asthma was presented in Figure 1 by age group. 
Risk factors for Staphylococcal enterotoxin (SE) sensitization 
First, we explored risk factors for SE sensitization. In univariate chi-squared tests 
(Supplementary Table E1), the relevant factors were identified as male sex, advanced age, 
atopy, current smoking, current alcohol use, diabetes mellitus and Clonorchis infection. Using 
multivariate logistic regression tests (Table 2), independent associations with SE sensitization 
were tested. Male sex, advanced age (≥ 61 years), atopy and current smoking were identified 
as independent risk factors for sensitization. In Spearman tests, serum SE-sIgE levels showed 
a positive correlation with pack-year smoking history (r = 0.247, P < 0.001). Diabetes 
mellitus was the only comorbid condition that was related to SE sensitization in univariate 
tests but only marginally related in multivariate tests (P = 0.057). Obesity (defined as BMI ≥ 
27.5 kg/m
2
) tended to increase the risk of SE sensitization (P = 0.085). Multiple 
correspondence analyses were performed to confirm the relationships between SE 
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sensitization and six relevant factors that were identified in multivariate logistic regression 
tests (P < 0.10). SE sensitization was closely correlated with male sex and smoking (Figure 2).   
Associations between SE sensitization and atopy 
The relationship between atopy and SE sensitization was further investigated. Statistical 
significance was found for most tested allergens including house dust mites, cockroaches, 
grass pollen, and tree pollens. The number of allergen sensitizations was also significantly 
correlated with SE sensitization (likelihood-ratio P = 0.002; Supplementary Table E2). After 
inclusion of SE sensitization as an additional independent variable, risk factors for atopy were 
investigated in multivariate logistic regression tests. To study dose relationships, SE-sIgE 
levels were categorized into tertile-based groups (T1: 0–0.06; T2: 0.07–0.26; T3: 0.27–50.68 
kU/L). High SE-sIgE showed a significant association with atopy [T3 vs. T1; odds ratio (OR) 
2.14, 95% confidence interval (CI) 1.26–3.65, P = 0.005] (Supplementary Table E3).  
Associations between SE sensitization and asthma 
Levels of SE-sIgE were compared according to the age of asthma onset and current clinical 
disease activity. Late-onset current asthma had significantly higher rates of SE sensitization 
compared to never asthma or other asthma phenotypes (Table 3); of interest, the late-onset 
current asthma was mostly non-atopic. To investigate independent associations between SE 
sensitization and late-onset current asthma, multivariate logistic regression tests were 
performed, with adjustments for SE sensitization risk factors, traditional risk factors (atopy, 
obesity and rhinitis), and demographic factors (residence area, age and sex). Late-onset 
current asthma was significantly associated with SE sensitization (OR 2.41, 95% CI 1.28–
4.55, P = 0.006). Using tertile-based SE-sIgE categories, the dose relationship confirmed the 
significant association with high SE-sIgE levels (Table 4).  
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Correlations between total IgE and SE-sIgE levels 
To test potential confounding effects between total IgE and SE-sIgE, their correlations were 
evaluated in linear regression models. In univariate linear regressions, relevant factors for 
total IgE levels were SE-sIgE (P < 0.001), sex (P < 0.001), smoking status (P < 0.001), 
Clonorchis infection (P < 0.001), atopy (P = 0.058), and alcohol use (P = 0.084). Multivariate 
linear regression analyses demonstrated that SE-sIgE was a stronger determining factor (Table 
5) than other parameters including male sex, current smoking, alcohol use, Clonorchis 
infection (or infection intensity defined by EPG) and atopy. The strong correlation between 
SE-sIgE and total IgE (Spearman’s r = 0.758, P < 0.001) was also presented in a scatter plot, 
as log-transformed (Figure 3).  
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Discussion 
The present analysis demonstrated that SE sensitization was highly prevalent and 
independently associated with late-onset current asthma among community-based older adult 
populations in Korea. SE sensitization had a strong positive relationship with advanced age (≥ 
61 years), male sex, current smoking and atopy. In addition, we found that SE-sIgE levels 
were the major determinants for total IgE.  
SE-sIgE is an emerging marker for asthma [7, 9]. However, there is limited evidence of its 
association with asthma in general population samples. In children/adolescents, two studies 
have been published on the association between SE sensitization and asthma [510 five-year-
old children in the UK [17] and 1,380 fourteen-year-old children in Australia [18]]. In adults, 
the GA
2
LEN survey has recently reported the significant links with asthma in a large-scale 
European general population (n=2,908, mean age 48.9 years) [14]. In this regard, the present 
study is addition to the knowledge in that this is the first community population-based report 
in Asian adults. Considering the homogeneous results across various European centers in 
GA
2
LEN, the present study supports the notion that the asthma-SE sIgE association is 
universally significant across continents and various age groups.  
Moreover, we here for the first time report that SE sensitization is significantly related to late-
onset adult asthma. As shown in Figure 1, the prevalence of asthma and SE sensitization 
increased with aging, whereas atopy decreased. A low atopy rate (5.3%) among late-onset 
older adult asthmatics indicates less impact of atopy in those subjects, compared to a younger 
population of adults [7]. As asthma is a heterogeneous disorder [1] and SE sensitization rate 
ranges from 38 to 76% of adult asthmatics [12], it is still uncertain that how SE is exactly 
involved in the asthma pathophysiology. However, we have shown before that specifically 
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severe non-atopic adult asthma was highly associated with SE-IgE [7], which supports the 
present findings.  
In this regard, the relationship between older age and SE sensitization is of note. As skin from 
older individuals has a reduced barrier function or an increased epidermal permeability to 
exogenous antigens [19], we presume that the risk of sensitization increases with aging. 
Compared with previous population-based studies, the SE sensitization rate was significantly 
higher among our control subjects (mean age 60.2 years, 26.1%) than among younger controls 
in the previous two studies [mean age 5 years, 7.5% in UK children [17] and mean age 14 
years, 17.9% in Australian controls [18]]. Although these data are not directly comparable 
because of substantial demographic differences, age could have an effect on SE sensitization, 
such that ‘older age’ may be a risk factor for SE sensitization and subsequently for late-onset 
adult asthma.  
Smoking is another risk factor for SE sensitization, which may have significant clinical 
implications. In our various statistical models and also in the GA
2
LEN analyses [14], smoking 
status was consistently found to have positive and close correlations with SE-sIgE levels. As S. 
aureus is inhaled in indoor dust and frequently colonizes the upper airways [3], we postulate 
that epithelial damage caused by smoke exposure increases the risk of staphylococcal 
enterotoxin penetration into subepithelial layers, thereby leading to SE-mediated stimulation 
of immune cells and sensitization.  
Interestingly, we found no independent effects of smoking on asthma when co-adjusted with 
SE sensitization which had stronger effects, despite that smoking is known as a risk factor for 
adult asthma [2]. Further studies are necessary to draw firm conclusions; however, it may be 
speculated that SE sensitization and smoking have common pathways in the asthma 
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pathogenesis, and that prior evidence for smoking on asthma could have been co-mediated by 
SE sensitization effects, at least in part.  
Our findings on the association with atopy confirm previous results from children/adolescent 
population studies [17, 18] and extend this knowledge into older adults. As it was a cross-
sectional analysis, we could not determine causal relationships between atopy and SE 
sensitization. However, on the basis of age-related prevalence patterns, we speculate that 
atopy could be a predisposing factor for SE sensitization. Atopic subjects may be more prone 
to S. aureus colonization and sensitization, as M2 macrophages, which are more frequent in 
the Th2 milieu, have reduced phagocytotic activity, which leads to increased risk of bacterial 
survival [20]. Conversely, there is also experimental evidence that nasal Staphylococcal 
enterotoxin B (SEB) administration enhances allergen sensitization in mice [21], and in in 
vitro studies using human dendritic cells (DC), SEB caused DCs to drive the Th2 polarization 
of naïve T cells [22]. 
The identification of SE-sIgE as a major determinant of total IgE level is another interesting 
finding. Total IgE, which is a traditional indicator of allergy, may have significant associations 
with demographic or environmental factors [23, 24], genetic factors [25], atopy [24] or 
parasitic infection [26]. We performed a comprehensive analysis of IgE in areas with high 
rates of endemic Clonorchis infection to identify the major determinants of total IgE levels. 
Interestingly, SE-sIgE levels were the most significant determinant, most likely because SE is 
a superantigen that promotes polyclonal IgE production [4]. These findings suggest that the 
interpretation of total IgE levels in previous studies should be reevaluated. Moreover, the 
potential confounding effects of total IgE need to be considered when interpreting 
multivariate analyses. Clinically, adult asthmatics frequently have increased serum total IgE 
but no evidence of atopy or parasitic infection; this effect could possibly be explained by SE-
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sIgE [7]. We suggest that SE-sIgE level should be included as a significant biomarker in 
epidemiological or clinical evaluations for adult allergic disorders. 
There is overwhelming evidence in animal studies and human mucosal models that 
staphylococcal enterotoxins break tolerance [21] and induce airway inflammation and IgE 
synthesis [27, 28]; however, there is no direct evidence for S. aureus enterotoxin pathogenesis 
in human airway disease. Although S. aureus is known to reside in the upper airways and skin 
[3], its presence in the lower airways has been contested. However, recent advances in 
metagenomics have challenged the ‘old dogma’ by demonstrating that the lower respiratory 
tracts of asthma patients are not sterile but rather have a high burden of commensal bacteria 
[29, 30]. Therefore, further studies are needed to directly demonstrate the role of S. aureus in 
the pathogenesis of asthma.  
The present study has several limitations. By using a cross-sectional survey, we could not 
determine causal relationships between parameters. Because the study participants were not 
randomly recruited but were volunteers from communities, selection biases may have existed. 
Recall bias may also be present, as outcomes like symptoms or medical history was based on 
participants’ recall. The results could not be generalized because the survey was not 
conducted nationwide. In addition, we could not draw any conclusions on early-onset asthma, 
due to a small number of early-onset current asthma cases. However, the selection of well-
defined local areas with endemic Clonorchis is a strength of the study. The demographic 
features of the present survey were different from previous studies [14, 17, 18]. Thus, the 
present findings are new addition to previous knowledge.  
In conclusion, we demonstrated that Staphylococcal sensitization is highly prevalent and 
significantly associated with late-onset current asthma among older adult community 
populations. Our identification of risk factors for SE sensitization may be useful in 
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understanding the pathophysiology of SE-mediated allergic disorders. In addition, the strong 
correlation between SE-sIgE and total IgE levels is further addition to its clinical significance. 
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Figure Legends 
 
Figure 1. Age-related prevalence of current asthma, atopy and Staphylococcal enterotoxin 
sensitization among study population.  
 
Figure 2. Multiple correspondence analysis map representing the relationships between 
Staphylococcal enterotoxin sensitization and six relevant factors that were identified in 
multivariate logistic regression tests 
 
Figure 3. Correlation between log-transformed total IgE and Staphylococcal enterotoxin 
specific IgE (SE sIgE) levels. The scatter plot is shown with the 95% confidence interval (CI) 
and the regression line.  
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Table 1. Baseline characteristics of study population according to residence areas 
Parameters Sancheong (n=605) Changwon (n=475) P value 
Age (yrs) 59.9 ± 12.1 60.6 ± 10.8 0.306 
Female sex (%) 64.0 61.3 0.362 
BMI (kg/m
2
) 23.5 ± 3.2 23.8 ± 3.2 0.130 
Smoking (%)    
 Never smoker 64.4 65.0 0.435 
 Ex-smoker 17.3 19.3  
 Current smoker 18.3 15.7  
Alcohol (%)    
 Never drinker 50.5 54.0 0.080 
 Ex-drinker 8.9 5.3  
 Current drinker 40.6 40.7  
Diabetes mellitus (%) 8.4 9.3 0.631 
Rhinitis
*
 (%) 16.9 16.1 0.706 
Current asthma
†
 (%) 5.8 6.1 0.954 
Atopy
‡
 (%) 12.3 11.4 0.649 
Clonorchis infection
§
 (%) 33.8 14.6 < 0.001 
FVC%pred 92.4 ± 15.9 94.6 ± 17.2 0.037 
FEV1%pred 108.3 ± 20.7 108.6 ± 20.6 0.891 
FEV1/FVC% 84.7 ± 8.4 82.9 ± 9.4 0.002 
SE-sIgE    
 Levels (kU/L) Median 0.14 (IQR 0.05–
0.41) 
Median 0.11 (IQR 0.04–
0.37) 
0.372 
 ≥ 0.35 kU/L (%) 27.6 26.3 0.636 
Total IgE (kU/L) 129.1 (IQR 43.4–358.2) 98.6 (IQR 35.9–307.3) 0.781 
Abbreviations: BMI, body mass index; FVC, forced vital capacity; FEV1, forced expiratory 
volume in 1 second; SE-sIgE, Staphylococcal enterotoxin specific IgE 
*
Rhinitis was defined by the question “Have you had a problem with sneezing, or a runny, or 
blocked nose without a cold in the last 12 months?”. 
†
Current asthma was defined as positive if the subjects had current wheeze (Have you had a 
wheezing or whistling in the chest during the last 12 months?) and methacholine airway 
hyperresponsiveness, or had used asthma medication within the last 12 months. 
‡
Atopy was defined as positive if the subjects had a positive skin response to any of tested 10 
inhalant allergens. 
§
Clonorchis infection was defined by stool sample analyses for the presence of eggs. 
P values were determined by t tests, Mann-Whitney tests, or chi-squared tests.  
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Table 2. Multivariate logistic regression for Staphylococcal enterotoxin sensitization  
SE sensitization (≥ 0.35 kU/L) as 
dependent variable (292 cases vs. 788 
controls) 
Adjusted OR (95% CI)* P value 
Residence area   
 Sancheong Reference  
Changwon 1.02 (0.74–1.39) 0.922 
Age group   
 ≤ 40 yrs Reference  
 41–50 yrs 1.77 (0.78–4.01) 0.173 
 51–60 yrs 2.17 (0.99–4.75) 0.053 
 61–70 yrs 2.74 (1.27–5.90) 0.010 
> 70 yrs 2.95 (1.33–6.57) 0.008 
Sex   
Female Reference  
Male 1.93 (1.21–3.07) 0.006 
BMI (kg/m
2
)   
 < 23 Reference  
 23.0–24.9 0.85 (0.58–1.25) 0.414 
 25.0–27.4 1.19 (0.79–1.79) 0.418 
 ≥ 27.5 1.58 (0.94–2.65) 0.085 
Smoking   
 Never smoker Reference  
 Ex-smoker 1.36 (0.82–2.25) 0.232 
 Current smoker 3.26 (2.03–5.24) < 0.001 
Alcohol   
 Never drinker Reference  
 Ex-drinker 0.92 (0.50–1.71) 0.800 
 Current drinker 1.13 (0.78–1.64) 0.516 
Diabetes mellitus   
 No Reference  
 Yes 1.61 (0.99–2.64) 0.057 
Atopy   
 No Reference  
 Yes 2.28 (1.45–3.59) < 0.001 
Clonorchis infection   
 No Reference  
 Yes 1.16 (0.83–1.68) 0.366 
Abbreviations: SE, Staphylococcal enterotoxin; OR, odds ratio; CI, confidence interval; BMI, 
body mass index 
Please see Table 1 for definitions. 
P values were determined by multivariate logistic regression tests.  
*
Adjusted for residence area, age group, sex, BMI category, smoking status, alcohol status, 
atopy, Clonorchis infection, and diabetes mellitus.  
Song et al. 25 
 
Table 3. Phenotype comparisons by asthma onset and current symptom activity 
 Never asthma
*
 
(n=992) 
Past asthma
†
 (n=28) Early-onset current 
asthma
‡
 (n=4) 
Late-onset current 
asthma
§
 (n=56) 
P values 
Age (yrs) 59.7 ± 11.6 63.6 ± 10.3 61.3 ± 6.6 66.7 ± 7.8 < 0.001
ll
 
Asthma onset (yrs)  46.8 ± 20.0 30.3 ± 6.3 57.2 ± 12.8 0.003
ll
 
Female sex (%) 62.7 75.0 75.0 57.6 0.437
¶
 
BMI (kg/m
2
) 23.6 ± 3.1 22.8 ± 3.0 25.4 ± 2.5 24.0 ± 4.2 0.229
ll
 
Smoking (%)      
 Never smoker 65.0 67.9 50.0 58.6 0.893
¶
 
 Ex-smoker 17.9 21.4 25.0 20.7  
 Current smoker 17.1 10.7 25.0 20.7  
Rhinitis (%) 15.7 28.0 0 26.3 0.056
¶
 
Atopy (%) 12.5 11.1 0 5.3 0.356
¶
 
SE-sIgE (kU/L) Median 0.12 (IQR 
0.04–0.37) 
Median 0.09 (IQR 
0.03–0.15) 
Median 0.12 (IQR 
0.05–0.23) 
Median 0.32 (IQR 
0.17–0.91) 
0.006
ll
 
SE-sIgE ≥ 0.35 kU/L 
(%) 
26.1 14.3 0.0 48.2 < 0.001
¶
 
Abbreviations: BMI, body mass index; SE, Staphylococcal enterotoxin; IQR, inter-quartile ranges 
See Table 1 for definition of current asthma, rhinitis and atopy.  
*
Never asthma was defined by no asthma diagnosis in history and no current asthma.  
†
Past asthma was defined by prior asthma diagnosis history but no current asthma. 
‡
Early-onset current asthma was defined by a participant-recalled asthma history starting before 40 years old, and also having current asthma.  
§
Late-onset current asthma was defined by a participant-recalled asthma history starting after 40 years old, and also having current asthma. 
ll
P values were determined by one-way ANOVA.  
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¶
P values were determined by chi-squared tests. 
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Table 4. Multivariate logistic regression tests for late-onset current asthma 
 Adjusted OR (95% CI)
*
 P value 
Residence area   
 Sancheong Reference  
 Changwon 1.07 (0.58–1.95) 0.836 
Age 1.09 (1.05–1.13) < 0.001 
Sex   
Female Reference  
Male 0.85 (0.36–.03) 0.719 
BMI (kg/m
2
)   
 < 23 Reference  
 23.0 – 24.9 0.98 (0.44–2.18) 0.954 
 25.0 – 27.4 1.05 (0.45–2.42) 0.918 
 ≥ 27.5 2.94 (1.25–6.91) 0.013 
Smoking   
 Never Reference  
 Ex- 1.32 (0.49–3.56) 0.589 
 Current 1.96 (0.71–5.35) 0.192 
Atopy   
 No Reference  
 Yes 0.28 (0.06–1.22) 0.090 
Rhinitis   
 No Reference  
 Yes 2.17 (1.04–4.50) 0.038 
SE-sIgE levels   
 Lowest tertile (–0.06 kU/L) Reference  
 Mid-tertile (0.07–0.26 kU/L) 2.93 (1.10–7.82) 0.031 
 Highest tertile (0.27–50.68 kU/L) 5.32 (2.07–13.6) 0.001 
Abbreviations: SE, Staphylococcal enterotoxin; OR, odds ratio; CI, confidence interval; BMI, 
body mass index 
Please see Tables 1 and 3 for definitions. 
P values were determined by multivariate logistic regression tests.  
*
Adjusted for residence area, age, sex, BMI category, smoking status, atopy, and rhinitis 
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Table 5. Multivariate linear regression for total IgE levels (kU/L) 
 P values
*
 β Std. Err. t 
SE-sIgE (kU/L) < 0.001 144.77 12.25 11.82 
Male sex 0.001 313.47 90.91 3.45 
Smoking status     
 Ex-smoking 0.712 36.78 99.62 0.37 
 Current smoking 0.016 233.58 97.00 2.41 
Alcohol status     
 Ex-drinker 0.472 -85.11 118.27 -0.72 
 Current drinker 0.032 142.95 66.40 2.15 
Atopy 0.639 41.18 87.67 0.47 
Clonorchis infection 0.043 131.78 65.07 2.03 
Abbreviations: SE, Staphylococcal enterotoxin 
Please see Table 1 for definitions. 
*
P values were determined by multivariate linear regression tests with adjustment for SE sIgE, 
sex, smoking status, alcohol status, atopy, and Clonorchis infection.  
 
